Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

New Mutations in Ciprofloxacin Resistant Strains of Pseudomonas aeruginosa Isolated from Guilan Province, Northern Iran

New Mutations in Ciprofloxacin Resistant Strains of Pseudomonas aeruginosa Isolated from Guilan... ISSN 0891-4168, Molecular Genetics, Microbiology and Virology, 2017, Vol. 32, No. 4, pp. 218–223. © Allerton Press, Inc., 2017. EXPERIMENTAL WORKS New Mutations in Ciprof loxacin Resistant Strains of Pseudomonas aeruginosa Isolated from Guilan Province, Northern Iran a b, b Saeid Rahbar Takrami , Najmeh Ranji *, and Fatemeh Hakimi Young Researchers and Elite Club, Rasht Branch, Islamic Azad University, Rasht, Iran Department of Biology, Faculty of Sciences, Rasht Branch, Islamic Azad University, Rasht, Iran *e-mail: n_ranji@iaurasht.ac.ir Received August 17, 2017 Abstract—Introduction. Pseudomonas aeruginosa (P. aeruginosa) is a gram-negative bacterium that continues to be a major cause of opportunistic nosocomial infections. In P. aeruginosa, several f luoroquinolones resis- tance mechanisms have been proposed such as mutations in the target enzymes GyrA and ParC and upregu- lation of efflux pump MexAB-OprM. Fluoroquinolones inhibit the target enzymes DNA gyrase and topoisomerase IV, each comprised of two subunits: GyrA and GyrB, and ParC and ParE, respectively. In addi- tion, f luoroquinolones were blocked by overexpression of MexAB-OprM induced through mutations in the regulatory genes mexR and nalC. Materials and methods. In this study, 44 P. aeruginosa strains were isolated from different clinical samples of burn and infection from patients in some hospitals http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Molecular Genetics, Microbiology and Virology Springer Journals

New Mutations in Ciprofloxacin Resistant Strains of Pseudomonas aeruginosa Isolated from Guilan Province, Northern Iran

Download PDF
6 pages

Loading next page...
 
/lp/springer_journal/new-mutations-in-ciprofloxacin-resistant-strains-of-pseudomonas-f8yWGK1NyC
Publisher
Springer Journals
Copyright
Copyright © 2017 by Allerton Press, Inc.
Subject
Life Sciences; Microbiology; Molecular Medicine
ISSN
0891-4168
eISSN
1934-841X
DOI
10.3103/S089141681704005X
Publisher site
See Article on Publisher Site

Abstract

ISSN 0891-4168, Molecular Genetics, Microbiology and Virology, 2017, Vol. 32, No. 4, pp. 218–223. © Allerton Press, Inc., 2017. EXPERIMENTAL WORKS New Mutations in Ciprof loxacin Resistant Strains of Pseudomonas aeruginosa Isolated from Guilan Province, Northern Iran a b, b Saeid Rahbar Takrami , Najmeh Ranji *, and Fatemeh Hakimi Young Researchers and Elite Club, Rasht Branch, Islamic Azad University, Rasht, Iran Department of Biology, Faculty of Sciences, Rasht Branch, Islamic Azad University, Rasht, Iran *e-mail: n_ranji@iaurasht.ac.ir Received August 17, 2017 Abstract—Introduction. Pseudomonas aeruginosa (P. aeruginosa) is a gram-negative bacterium that continues to be a major cause of opportunistic nosocomial infections. In P. aeruginosa, several f luoroquinolones resis- tance mechanisms have been proposed such as mutations in the target enzymes GyrA and ParC and upregu- lation of efflux pump MexAB-OprM. Fluoroquinolones inhibit the target enzymes DNA gyrase and topoisomerase IV, each comprised of two subunits: GyrA and GyrB, and ParC and ParE, respectively. In addi- tion, f luoroquinolones were blocked by overexpression of MexAB-OprM induced through mutations in the regulatory genes mexR and nalC. Materials and methods. In this study, 44 P. aeruginosa strains were isolated from different clinical samples of burn and infection from patients in some hospitals

Journal

Molecular Genetics, Microbiology and Virology – Springer Journals

Published: May 30, 2018

References

  • In vivo development of antimicrobial resistance in Pseudomonas aeruginosa strains isolated from the lower respiratory tract of Intensive Care Unit patients with nosocomial pneumonia and receiving antipseudomonal therapy
    Riou, M.; Carbonnelle, S.; Avrain, L.
  • Frequency of Pseudomonas aeruginosa serotypes in burn wound infections and their resistance to antibiotics
    Estahbanati, H.K.; Kashani, P.P.; Ghanaatpisheh, F.
  • Crystal structure of MexZ, a key repressor responsible for antibiotic resistance in Pseudomonas aeruginosa
    Alguel, Y.; Lu, D.; Quade, N.; Sauter, S.; Zhang, X.
  • Detection of gyrA mutations among 335 Pseudomonas aeruginosa strains isolated in Japan and their susceptibilities to fluoroquinolones
    Takenouchi, T.; Sakagawa, E.; Sugawara, M.
  • Reduction of the fitness burden of quinolone resistance in Pseudomonas aeruginosa
    Kugelberg, E.; Lofmark, S.; Wretlind, B.; Andersson, D.I.
  • Detection of point mutations associated with antibiotic resistance in Pseudomonas aeruginosa
    Gorgani, N.; Ahlbrand, S.; Patterson, A.; Pourmand, N.
  • Mutations in GyrA, ParC, MexR and NfxB in clinical isolates of Pseudomonas aeruginosa
    Higgins, P.G.; Fluit, A.C.; Milatovic, D.; Verhoef, J.; Schmitz, F.J.
  • Interplay of efflux system, ampC, and oprD expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolates
    Quale, J.; Bratu, S.; Gupta, J.; Landman, D.
  • Critical biophysical properties in the Pseudomonas aeruginosa efflux gene regulator MexR are targeted by mutations conferring multidrug resistance
    Andresen, C.; Jalal, S.; Aili, D.
  • Chlorinated phenols control the expression of the multidrug resistance efflux pump MexAB-OprM in Pseudomonas aeruginosa by interacting with NalC
    Ghosh, S.; Cremers, C.M.; Jakob, U.; Love, N.G.
  • The neglected intrinsic resistome of bacterial pathogens
    Fajardo, A.; Martinez-Martin, N.; Mercadillo, M.
  • Antibiotic resistance in food lactic acid bacteria–a review
    Mathur, S.; Singh, R.
  • Pseudomonas aeruginosa: resistance to the max
    Poole, K.
  • Characterization of fluoroquinolone and carbapenem susceptibilities in clinical isolates of levofloxacin-resistant Pseudomonas aeruginosa
    Muramatsu, H.; Horii, T.; Takeshita, A.; Hashimoto, H.; Maekawa, M.
  • Mutations in the gyrA and parC genes in fluoroquinoloneresistant clinical isolates of Pseudomonas aeruginosa
    Nakano, M.; Deguchi, T.; Kawamura, T.
  • Molecular mechanisms of fluoroquinolone resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients
    Jalal, S.; Ciofu, O.; Hoiby, N.; Gotoh, N.; Wretlind, B.
  • gyrA and parC mutations in quinoloneresistant clinical isolates of Pseudomonas aeruginosa from Nini Hospital in north Lebanon
    Salma, R.; Dabboussi, F.; Kassaa, I.; Khudary, R.; Hamze, M.
  • Quantitative contributions of target alteration and decreased drug accumulation to Pseudomonas aeruginosa fluoroquinolone resistance
    Bruchmann, S.; Dotsch, A.; Nouri, B.; Chaberny, I.F.; Haussler, S.
  • Clinical strains of Pseudomonas aeruginosa overproducing MexAB-OprM and MexXY efflux pumps simultaneously
    Llanes, C.; Hocquet, D.; Vogne, C.; Benali-Baitich, D.; Neuwirth, C.; Plesiat, P.
  • Carbapenem resistance mechanisms in Pseudomonas aeruginosa clinical isolates
    Pai, H.; Kim, J.; Lee, J.H.; Choe, K.W.; Gotoh, N.
  • In vivo emergence of multidrugresistant mutants of Pseudomonas aeruginosa overexpressing the active efflux system MexA-MexB-OprM
    Ziha-Zarifi, I.; Llanes, C.; Kohler, T.; Pechere, J.C.; Plesiat, P.
  • Mutations affecting DNA-binding activity of the MexR repressor of mexR-mexA-mexB-oprM operon expression
    Saito, K.; Akama, H.; Yoshihara, E.; Nakae, T.